CCBR-SYNARC to expand its Electronic Data Capture capabilities for use in imaging clinical trials

NewsGuard 100/100 Score

CCBR-SYNARC, the world's leading provider of medical image analysis, biochemical marker, and clinical research center services to the pharmaceutical and biotechnology industries, announced the expansion of its Electronic Data Capture ("EDC") capabilities for use in imaging clinical trials.

SYNARC has been using EDC to support global imaging trials since 2004. With the release of the enhanced SynarcConnect(SM) service, SYNARC has further improved its data and image transfer capabilities to meet the demanding standards of its in-house radiologists, scientific experts, and global sponsors.

"This latest release of our EDC system will improve the sponsor and investigator site experience in interacting with our service delivery teams," stated Herve Girsault, CEO. "As we constantly strive to achieve excellence in our service levels, I'm pleased with the results and reception of the enhanced SynarcConnect(SM) service."

The complexity of moving images and data from thousands of investigator sites across the globe to SYNARC's in-house readers is streamlined through the use of Web-based electronic data capture. Investigator sites only need access to the Internet to benefit from the electronic transmittal forms, study documents and electronic image transfer capabilities. Sponsors benefit from the decreased time between image acquisition and analysis, relief from costs associated with courier services, and efficient access to real-time study information via SynarcConnect(SM)'s Web-based reporting. Investigator sites also benefit from faster cycle times between image acquisition and centralized image quality review, resulting in improved protocol adherence and overall image quality.

Source:

CCBR-SYNARC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy